Exane Derivatives’s Arcturus Therapeutics ARCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
Sell
-1,652
Closed -$68.2K 1029
2021
Q1
$68.2K Buy
+1,652
New +$68.2K 0.02% 469